Information  X 
Enter a valid email address

Novacyt S.A. EUR 1/15th (CDI) (NCYT)

Date Time Source Announcement
13 May 2022 7:00 am
RNS
Notice of Annual General Meeting
03 May 2022 12:21 pm
RNS
Liquidity Agreement Update and Total Voting Rights
28 Apr 2022 7:00 am
RNS
Full year results and update on growth strategy
26 Apr 2022 7:00 am
RNS
DHSC dispute update
20 Apr 2022 7:00 am
RNS
Notice of Results and Investor Presentation
12 Apr 2022 7:00 am
RNS
Approval of COVID-19 test under CTDA legislation
01 Apr 2022 11:45 am
RNS
Liquidity Agreement Update and Total Voting Rights
25 Mar 2022 5:25 pm
RNS
Director/PDMR Shareholding
18 Mar 2022 6:00 pm
RNS
Director/PCA Dealing
15 Mar 2022 2:30 pm
RNS
Director/PDMR Shareholding
11 Mar 2022 8:00 am
RNS
Holdings in Company
01 Mar 2022 1:00 pm
RNS
Liquidity Agreement Update and Total Voting Rights
18 Feb 2022 4:05 pm
RNS
Holdings in Company
17 Feb 2022 7:00 am
RNS
Approval of COVID-19 test under CTDA legislation
15 Feb 2022 4:00 pm
RNS
Holdings in Company
04 Feb 2022 7:00 am
RNS
Long Term Incentive Plan
01 Feb 2022 2:30 pm
RNS
Liquidity Agreement and Total Voting Rights
25 Jan 2022 7:00 am
RNS
Strategy and Full Year 2021 Trading Update
04 Jan 2022 4:30 pm
RNS
Liquidity Agreement and Total Voting Rights
01 Dec 2021 2:30 pm
RNS
Total Voting Rights
26 Nov 2021 7:00 am
RNS
Approval of COVID-19 test under CTDA legislation
02 Nov 2021 7:00 am
RNS
Validation of COVID-19 tests in the UK under CTDA
01 Nov 2021 5:30 pm
RNS
Liquidity Agreement and Total Voting Rights
19 Oct 2021 4:15 pm
RNS
Results of annual general meeting
01 Oct 2021 2:30 pm
RNS
Total Voting Rights
30 Sep 2021 7:00 am
RNS
R&D update
29 Sep 2021 5:00 pm
RNS
Notice of AGM
  7:00 am
RNS
Notice of rescheduled AGM
27 Sep 2021 7:00 am
RNS
Half year 2021 results
16 Sep 2021 7:00 am
RNS
Proposed accounting treatment of DHSC dispute
13 Sep 2021 7:00 am
RNS
AGM voting
01 Sep 2021 11:30 am
RNS
Liquidity Agreement and Total Voting Rights
20 Aug 2021 7:00 am
RNS
Notice of AGM
18 Aug 2021 7:00 am
RNS
Half Year Update
05 Aug 2021 7:00 am
RNS
Notice of investor meeting
02 Aug 2021 1:30 pm
RNS
Total Voting Rights
29 Jul 2021 7:00 am
RNS
David Allmond to be CEO, Graham Mullis to retire
06 Jul 2021 2:40 pm
RNS
Director/PDMR Shareholding
01 Jul 2021 2:30 pm
RNS
Liquidity Agreement and Total Voting Rights
29 Jun 2021 7:00 am
RNS
Publication of Annual Report
  7:00 am
RNS
Expansion of PathFlow COVID-19 LFT portfolio
22 Jun 2021 7:00 am
RNS
Full year 2020 results and update on strategy
18 Jun 2021 7:00 am
RNS
Update on Notice of 2020 Full Year Results
03 Jun 2021 7:00 am
RNS
Launch of two new PCR COVID-19 assays
01 Jun 2021 2:00 pm
RNS
Liquidity Agreement and Total Voting Rights
26 May 2021 7:00 am
RNS
Launch of VersaLab Portable
21 May 2021 7:00 am
RNS
DHSC Dispute Update
17 May 2021 7:00 am
RNS
Inclusion of SNPsig in the NHS England Framework
04 May 2021 1:00 pm
RNS
Total Voting Rights
  7:00 am
RNS
Novacyt donates 1 million COVID-19 tests to UNICEF
23 Apr 2021 7:00 am
RNS
R&D and UK operational update
22 Apr 2021 7:00 am
RNS
Notice of Results
09 Apr 2021 12:30 pm
RNS
Trading Update
01 Apr 2021 1:40 pm
RNS
Total Voting Rights
24 Mar 2021 7:00 am
RNS
Launch of VariPLEX CE-Mark test
17 Mar 2021 7:11 am
RNS
Launch of mobile processing laboratories
15 Mar 2021 4:45 pm
RNS
Holdings in Company
  11:30 am
RNS
Holding(s) in Company
12 Mar 2021 11:00 am
RNS
Holdings in Company
01 Mar 2021 2:30 pm
RNS
Liquidity Agreement and Total Voting Rights

a d v e r t i s e m e n t